Why Elan Is Inviting Royalty Pharma Bid

June 17 (Bloomberg) -- Elan Corp. is seeking a buyer and will invite Royalty Pharma, whose $6.7 billion bid it rejected, to participate, suggesting the two companies may end a standoff that has lasted almost four months. Jonathan Ferro reports on Bloomberg Television's "Countdown." (Source: Bloomberg)
U.S. Earnings: Do They Reflect Fundamentals?
44:09 - Janney Montgomery Scott Chief Investment Strategist Mark Luschini discusses U.S. earnings season, the strong dollar and where he sees opportunity. He speaks to Bloomberg’s Shery Ahn on “First Up.” (Source: Bloomberg)
  • Zscaler Raises $100M at $1B Valuation: Is an IPO Ahead?
  • Fixing the Diversity Challenge in Silicon Valley
  • An Astronaut's Thoughts on Returning to Earth